{"version":"1.0","provider_name":"Avalere Health Advisory","provider_url":"https:\/\/advisory.avalerehealth.com","title":"IPAY 2027 Negotiated Drugs Expand Impact on Beneficiaries | Avalere Health Advisory","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"TKbCJ6FOsl\"><a href=\"https:\/\/advisory.avalerehealth.com\/insights\/ipay-2027-negotiated-drugs-expand-impact-on-beneficiaries\">IPAY 2027 Negotiated Drugs Expand Impact on Beneficiaries<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/advisory.avalerehealth.com\/insights\/ipay-2027-negotiated-drugs-expand-impact-on-beneficiaries\/embed#?secret=TKbCJ6FOsl\" width=\"600\" height=\"338\" title=\"&#8220;IPAY 2027 Negotiated Drugs Expand Impact on Beneficiaries&#8221; &#8212; Avalere Health Advisory\" data-secret=\"TKbCJ6FOsl\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","thumbnail_url":"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2020\/08\/3019-1-Kylie_Stengel_600x400-e1597870657980.jpg","thumbnail_width":600,"thumbnail_height":400,"description":"On January 17, the Centers for Medicare &amp; Medicaid Services (CMS) released the list of the next 15 Part D drugs that have been selected for Medicare negotiation for Initial Price Applicability Year (IPAY) 2027. This list follows the first 10 selected drugs for IPAY 2026. While MFPs will apply specifically to the 25 selected&hellip;"}